WIRE — The Wegovy pill's fast launch had primed investors for the possibility of a blowout as Novo fights to regain market share from Lilly. Yet the result raised concerns about the company's longer-term...
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.